Niloufar Soltanian-Moffett
Optometrist · Atlanta, GANPI 1366875122
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 168 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,725, 6.3 times the $273 reported in 2019. Among optometrist clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 168 payments — averaging $39.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$2K
- Sun Pharmaceutical Industries Inc.$1K
- AbbVie$923
- Novartis$465
- Dompe US, Inc.$437
- Alcon$420
- plus $1K from 15 others
What the payments were for
- Food & beverage$6,648100%
- Gifts$190%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 12 | $1,523 |
| Sun Pharmaceutical Industries Inc. | 33 | $1,476 |
| AbbVie(2 entities) | 40 | $923 |
| Novartis | 16 | $465 |
| Dompe US, Inc. | 8 | $437 |
| Alcon | 10 | $420 |
| Thea Pharma Inc. | 5 | $248 |
| Amgen(2 entities) | 5 | $189 |
| Bausch & Lomb Americas Inc. | 9 | $188 |
| Oyster Point Pharma, Inc. | 6 | $146 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 6 | $120 |
| Coopervision Inc. | 1 | $111 |
| Sight Sciences, Inc. | 6 | $111 |
| Aerie Pharmaceuticals, Inc. | 4 | $78 |
| Johnson & Johnson Vision Care, Inc. | 1 | $77 |
| Akorn, Inc. | 1 | $39 |
| Harrow Eye, LLC | 1 | $29 |
| Ocular Therapeutix, Inc. | 1 | $24 |
| Genentech USA, Inc. | 1 | $23 |
| Eyevance Pharmaceuticals LLC | 1 | $20 |
| Carl Zeiss Meditec AG | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CEQUA$835
- Oxervate$233
- iDoseTR$204
- iStent Infinite$204
- iStent Trabecular Micro-Bypass System Model iS3$180
- KXL System$179
- Photrexa Viscous and Photrexa$179
- CE-marked KXLA system$167
- iDose$154
- iStent inject W$142
- XELPROS$128
- LUMIGAN$125
- IYUZEH$113
- Clariti Contact Lens$111
- XIIDRA$109
How this compares
$6,667 in reported general payments places this provider in the 90th percentile of 1,285 optometrist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 34 | $628 |
| Prednisolone Acetate | 12 | $394 |
| Timolol Maleate | 13 | $41 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Atlanta
- Joshua JohnstonAtlanta$993K
- Amber ZaunbrecherAtlanta$99K
- Emily LoveAtlanta$35K
- Carla AndersonAtlanta$29K
- Sarah FlanaganAtlanta$21K
- Anisha HajiAtlanta$19K
- Anar MauryaAtlanta$18K
- Jonathan ChenAtlanta$15K
- Heer VaishnavAtlanta$14K
- Mohammad AljabiAtlanta$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.